Study to Assess the Safety, Tolerability of JPI-547 in Combination With Modified FOLFIRINOX or Gemcitabine-nab-paclitaxel in Patients With Locally Advanced and Metastatic Pancreatic Cancer
Abroad (travel likely)RecruitingPHASE1, PHASE2
Conditions
Pancreatic Ductal Adenocarcinoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Seoul National University Bundang Hospital, Gyeonggi-do, South Korea
Contact: Study coordinator (JW Kim)Samsung Medical Center, Seoul, South Korea
Contact: Study coordinator (JO Pack)Seoul national university hospital, Seoul, South Korea
Contact: Study coordinator (dy Oh)Severance Hospital, Seoul, South Korea
Contact: Study coordinator (HJ Choi)